{"organizations": [], "uuid": "bd2e0251ff509320acb3d06c20bac702ad281a5a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/02/the-associated-press-endologix-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Endologix: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-03T03:17:00.000+03:00", "replies_count": 0, "uuid": "bd2e0251ff509320acb3d06c20bac702ad281a5a"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/02/the-associated-press-endologix-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Endologix: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "irvine", "sentiment": "none"}, {"name": "irvine", "sentiment": "none"}], "organizations": [{"name": "endologix inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}, {"name": "endologix", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Wednesday reported a loss of $19.8 million in its first quarter.\nThe Irvine, California-based company said it had a loss of 24 cents per share. Losses, adjusted for non-recurring costs and to extinguish debt, were 16 cents per share.\nThe results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.\nThe medical device company posted revenue of $42.3 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $41.3 million.\nEndologix expects a full-year loss of 95 cents to 89 cents per share, with revenue in the range of $170 million to $180 million.\nIn the final minutes of trading on Wednesday, the company's shares hit $4.36. A year ago, they were trading at $7.42.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ELGX at https://www.zacks.com/ap/ELGX", "external_links": ["https://www.zacks.com/ap/ELGX", "http://automatedinsights.com/ap"], "published": "2018-05-03T03:17:00.000+03:00", "crawled": "2018-05-03T09:25:02.000+03:00", "highlightTitle": ""}